Literature DB >> 15102251

Opioid drugs: a comparative survey of therapeutic and "street" use.

D T Cowan1, L G Allan, S E Libretto, P Griffiths.   

Abstract

OBJECTIVES: The prescription of strong opioid analgesics for chronic non-cancer pain (CNCP) is described as controversial and can result in misidentification of patients as drug abusers or individuals with an addiction. This study compared the effects of opioid drugs on CNCP patients and "street" users. SUBJECTS/
SETTING: The groups comprised 36 CNCP patients attending a pain clinic and 39 street users, recruited on London streets.
DESIGN: CNCP patients were interviewed in a pain clinic and street users in a street setting. A questionnaire was used to assess drug craving, dose escalation, cessation of use, compulsion to use, effects on career, relationships and activities, experience of "highs," and problems due to intoxication. To assess physiological dependence, subjects answered questions on specific effects e.g. stomach pains, nausea/vomiting, cramps/aches, etc.). Efficacy was assessed in CNCP patients by determining analgesia and physical function.
RESULTS: CNCP patients started therapy in the low dose range for oral morphine (</=60 mg/day) and most (83%) did not move into a higher dose range once adequate levels of analgesia were attained. Street users started smoking heroin intermittently, before daily use. Most escalated their dose by increasing the amount used and by switching from smoking to injecting. Unlike CNCP patients, street users demonstrated patterns of compulsive drug use, social problems and intoxication. Only 3 / 31 (9.5%) pain patients that discontinued opioid therapy reported withdrawal symptoms on abstaining from the drug compared to 35 (89.5%) of street users.
CONCLUSION: Findings suggest that CNCP patients prescribed strong opioid analgesics derive more benefit than harm.

Entities:  

Year:  2001        PMID: 15102251     DOI: 10.1046/j.1526-4637.2001.01026.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  9 in total

1.  Non-medical use of prescription opioids and public health in Canada: an urgent call for research and interventions development.

Authors:  Benedikt Fischer; Jürgen Rehm; Brian Goldman; Svetlana Popova
Journal:  Can J Public Health       Date:  2008 May-Jun

Review 2.  Opioid misuse in gastroenterology and non-opioid management of abdominal pain.

Authors:  Eva Szigethy; Mitchell Knisely; Douglas Drossman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-15       Impact factor: 46.802

3.  Effects of repeated morphine on intracranial self-stimulation in male rats in the absence or presence of a noxious pain stimulus.

Authors:  Laurence L Miller; Ahmad A Altarifi; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2015-08-10       Impact factor: 3.157

4.  The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone.

Authors:  Jermaine D Jones; Maria A Sullivan; Jeanne Manubay; Suzanne K Vosburg; Sandra D Comer
Journal:  Neuropsychopharmacology       Date:  2010-10-27       Impact factor: 7.853

5.  Differential tolerance to morphine antinociception in assays of pain-stimulated vs. pain-depressed behavior in rats.

Authors:  Ahmad A Altarifi; S Stevens Negus
Journal:  Eur J Pharmacol       Date:  2014-12-18       Impact factor: 4.432

6.  Escalation and reinstatement of fentanyl self-administration in male and female rats.

Authors:  Samantha G Malone; Peggy S Keller; Lindsey R Hammerslag; Michael T Bardo
Journal:  Psychopharmacology (Berl)       Date:  2021-04-24       Impact factor: 4.530

Review 7.  Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human.

Authors:  Michael M Morgan; MacDonald J Christie
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

8.  Persistent peripheral inflammation attenuates morphine-induced periaqueductal gray glial cell activation and analgesic tolerance in the male rat.

Authors:  Lori N Eidson; Anne Z Murphy
Journal:  J Pain       Date:  2013-02-05       Impact factor: 5.820

Review 9.  Opioids and the treatment of chronic pain: controversies, current status, and future directions.

Authors:  Andrew Rosenblum; Lisa A Marsch; Herman Joseph; Russell K Portenoy
Journal:  Exp Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.